Adline Chem Lab share price

Extreme risk
  • 67%Low risk
  • 67%Moderate risk
  • 67%Balanced risk
  • 67%High risk
  • 67%Extreme risk
  • 13.86(0.00%)
    May 14, 2025 10:30:00 AM IST
    • NSE
    • BSE
  • Vol : 0 (NSE + BSE)
    Last 20 day avg : 0.24 K

Adline Chem Lab is trading -% upper at Rs 13.86 as compared to its last closing price. Adline Chem Lab has given -37.71% in this year & 6.04% in the last 5 days. The company posted a net profit of 0.21 Crores in its last quarter.Listed peers of Adline Chem Lab include Tiaan Consumer (4.64%), Shamrock Industrial (-%), Adline Chem Lab (-%).The Mutual Fund holding in Adline Chem Lab was at -% in . The MF holding has - from the last quarter. The FII holding in Adline Chem Lab was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on May 16, 2025, 05:13 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.02
    Low volatility
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
0.00
Highest
0.00
52 week range
Lowest
9.40
Highest
26.01
Adline Chem Lab Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsCompany has registered a profit of 0.21 cr vs a loss of 0.09 cr in the same quarter last year.
    • financial-insightsEarnings are insufficient to cover the interest expenses on outstanding debt
Adline Chem Lab Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 13.60
  • R2
  • 14.12
  • R3
  • 14.39
Pivot13.33
  • S1
  • 12.81
  • S2
  • 12.54
  • S3
  • 12.02
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Adline Chem Lab Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Tiaan Consumer
Bullish
8.804.6419.70-1.18--
Shamrock Industrial
Bullish
15.00-8.14-4.71--
Adline Chem Lab
Neutral
13.86-8.11---
Hindustan Bio Sciences
Bearish
7.30-7.48136.179.75-317.88
Ganga Pharmaceuticals
Moderately Bearish
13.51-6.53191.600.93-5.60
Adline Chem Lab Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Adline Chem Lab is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) does not have a high stake in the company
    • InsightsFIIs are not invested in this company
    • InsightsMutual Funds are not invested in this company.
    Adline Chem Lab Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-09Audited Results
    2025-02-04Quarterly Results
    2024-12-11Others
    2024-11-13Quarterly Results
    2024-10-29Quarterly Results
    About the company Adline Chem Lab
    • IndustryBiotechnology & Drugs
    • ISININE276T01018
    • BSE Code524604
    • NSE Code
    Adline Chem Lab Limited is an India-based company. The Company is engaged in the business of marketing pharmaceutical products. The Company operates in one segment: pharmaceutical products. The Company's products for the domestic market include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care and hepatocare. Its products for the international market include tablets, capsules and injections. Its veterinary products include B Complex Liver Extract with Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP and Tetracyclin-bolus Tablets. It also offers educational supplements. It offers manufacturing facilities for tablets, capsules, liquid orals and small volume parentals for contract manufacturing.
    • Management Info
    • Kuldip ParekhChief Financial Officer
    • Ritu SinghCompany Secretary, Compliance Officer
    • Sarang PathakManaging Director
    Adline Chem Lab Share Price FAQs

    Adline Chem Lab is trading at 13.86 as on Wed May 14 2025 05:00:00. This is -% upper as compared to its previous closing price of 13.86.

    The market capitalization of Adline Chem Lab is 8.11 Cr as on Wed May 14 2025 05:00:00.

    The 52 wk high for Adline Chem Lab is 26.01 whereas the 52 wk low is 9.40

    Adline Chem Lab can be analyzed on the following key metrics -

    • TTM P/E:
    • Sector P/E: -
    • Dividend Yield: 0.00%
    • D/E ratio: -

    Adline Chem Lab reported a net profit of -0.13 Cr in 2025.